Literature DB >> 301772

Deoxyadenosine metabolism and toxicity in cultured L5178Y cells.

J K Lowe, B Gowans, L Brox.   

Abstract

The growth of cultured L5178Y cells is inhibited by relatively low concentrations fo deoxyadenosine in the presence of deoxycoformycin, an inhibitor of adenosine deaminase. Cell viability is reduced, presumably as a consequence of the induced state of unbalanced growth which is characterized by inhibition in DNA synthesis, accumulation of cells in G1 or early S phase, a continuation in RNA synthesis, and increasing cell volume. The intracellular concentrations of purine and pyrimidine ribonucleoside phosphates remain essentially unchanged. The significant changes in the intracellular deoxynucleoside triphosphate pools are an increase in deoxyadenosine triphosphate and a decrease in deoxycytidine triphosphate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301772

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.

Authors:  R O Dillman; A L Yu; C N Qiao
Journal:  West J Med       Date:  1988-03

Review 2.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.

Authors:  J M Wilson; B S Mitchell; P E Daddona; W N Kelley
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

4.  Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

Authors:  B S Mitchell; E Mejias; P E Daddona; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.

Authors:  M S Hershfield; N M Kredich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

6.  "Reverse" carbocyclic fleximers: synthesis of a new class of adenosine deaminase inhibitors.

Authors:  Sarah C Zimmermann; Joshua M Sadler; Peter I O'Daniel; Nathaniel T Kim; Katherine L Seley-Radtke
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2013       Impact factor: 1.381

7.  Adenosine and deoxyadenosine toxicity in colony assay systems for human T-lymphocytes, B-lymphocytes, and granulocytes.

Authors:  L W Brox; E Pollock; A Belch
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Treatment of multiple myeloma with deoxycoformycin.

Authors:  A R Belch; J F Henderson; L W Brox
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  ATP depletion as a consequence of adenosine deaminase inhibition in man.

Authors:  M F Siaw; B S Mitchell; C A Koller; M S Coleman; J J Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.